# MOMENTUM 3 Continued Access Protocol

Study · id `cardio:ct-nct02892955` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02892955](<https://clinicaltrials.gov/study/NCT02892955>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02892955

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1685 participants.

## Technical summary

Registry record NCT02892955. Allocation not applicable; no masking; primary purpose treatment. Start 2016-08 (actual); primary completion 2020-12 (actual). Results posted on 2022-03-03.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1685 participants (enrolled count; ClinicalTrials.gov record NCT02892955, source copy `cardio:ctgov-nct02892955-2022-06-27`, retrieved 2026-10-26)
- Started: 2016-08 (actual) (ClinicalTrials.gov record NCT02892955, source copy `cardio:ctgov-nct02892955-2022-06-27`, retrieved 2026-10-26)
- Primary completion: 2020-12 (actual) (ClinicalTrials.gov record NCT02892955, source copy `cardio:ctgov-nct02892955-2022-06-27`, retrieved 2026-10-26)
- Completion: 2021-03 (actual) (ClinicalTrials.gov record NCT02892955, source copy `cardio:ctgov-nct02892955-2022-06-27`, retrieved 2026-10-26)
- Results first posted: 2022-03-03 (ClinicalTrials.gov record NCT02892955, source copy `cardio:ctgov-nct02892955-2022-06-27`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02892955, source copy `cardio:ctgov-nct02892955-2022-06-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02892955-2022-06-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: MOMENTUM 3 Continued Access Protocol
- Acronym: MOMENTUM 3 CAP
- Condition: Advanced Refractory Left Ventricular Heart Failure
- Intervention (Device): HeartMate 3 LVAS
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 1393ff59b6cac1753d963e71a9cd56d2c5ebdcb40509924d141447ab3a005490
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
